10 Hot Stocks to Watch — Monday, June 29, 2026

Lucid shares jumped 15.62% today after investor enthusiasm crystallized around its role as Uber's dedicated autonomous vehicle supplier, lifting the stock above $5.90 for the first time in weeks. However, the rally masks deteriorating fundamentals: the company is slashing 18% of U.S. workforce, eliminating its COO role, and burning cash faster than production can offset. Options traders are signaling conviction—call-to-put ratio sits at 1.95 with heavy buying in $5.50–$6.00 calls expiring early July—but the $4.47 52-week low remains a critical support level to monitor.

Moderna rallied 12.59% Friday, approaching its 52-week high of $69.29, after unveiling expanded oncology and autoimmune programs at an investor day. The biotech is pivoting beyond Covid vaccines with solid-tumor targeting and AI-powered drug discovery—a narrative that's resonating despite broad tech selloffs. Options markets are aggressively bullish: call-to-put ratio of 23.35 with heavy clustering at $68–$75 strikes through July 2026, signaling conviction in sustained upside toward $72. Watch the $70 level as near-term resistance.

ServiceNow rocketed nearly 10% Friday as investors reassessed the software sector selloff, with the stock recouping losses amid renewed appetite for enterprise workflow automation plays. The IBM partnership announcement addressing enterprise AI barriers catalyzed buying, while CIO spending surveys signal stronger software outlays ahead. Options traders are heavily long, with a 2.38 call-to-put ratio and robust volume in $100–$105 calls expiring early July, signaling confidence above resistance. Watch the $105 level; a close above that targets $120 over the next 4–6 weeks.

Snowflake jumped 9.64% to $248.96 following news that Unlimitail selected the cloud platform to power a Global Retail Media Data Hub across Europe and LATAM. The options market is pricing in sustained momentum, with call-to-put ratio at 5.23 and heavy volume stacked in the $240–$250 strike zone ahead of July 2 expiration. Traders are positioning for a test of the $255 level, though elevated beta of 1.355 signals elevated volatility risk.

AST SpaceMobile surged 8.88% to $71.45 on accelerating satellite deployment—BlueBirds 8, 9, and 10 are live, with 11–13 targeted for August launch. The company is now executing a one-to-two-month cadence toward its 37-satellite constellation, addressing earlier execution concerns. Options markets are leaning decidedly bullish: a 1.89 call-to-put ratio and heavy volume in $75–$85 calls expiring July 2 signal traders betting on a break above $80 ahead of the next Cape Canaveral launch. Watch the $80 level as a critical pivot.

Eli Lilly surged 7.13% to $1,208.12, near its 52-week peak, propelled by European regulatory approval for cancer drug Jaypirca and plans to launch its oral weight-loss therapy across Europe in late 2026. A fresh Leerink price-target hike to $1,232 validates momentum in the pharma giant's oncology and GLP-1 franchises. Options flow confirms bullish conviction: call-to-put ratio of 1.81 shows heavy upside positioning, with notable volume stacking in $1,300–$1,500 calls expiring mid-July, suggesting traders are pricing breakouts above current levels.

Caterpillar tumbled 5.63% today to $997.47, dragging the Dow lower despite record AI data center power backlogs and Russell Top 50 inclusion. The industrial heavyweight is caught in cross-currents: fundamental strength from battery-electric truck trials and energy infrastructure demand colliding with sector-wide weakness and profit-taking. Options markets are decidedly bearish, with a 0.49 call-put ratio and heavy put positioning at $730–$740 strikes through July 2026, signaling traders see downside risk. Watch the $950 support level; a close below it could trigger further institutional selling.

Robinhood jumped 5.6% today, extending its best quarter since September on fresh analyst optimism. BTIG initiated coverage with a Buy rating and $125 price target, implying 27% upside from current levels. Options markets are pricing in sustained momentum, with heavy call volume clustered around $100–$120 strikes through mid-2026, while the 4.72 call-to-put ratio signals institutional conviction. Watch $100 as support and $120 as the near-term resistance level where technicals align with bullish derivative positioning.

Rivian surged 5.2% to $15.63 on renewed praise for its R1T pickup design and R2 SUV capabilities, with British motoring journalist James May endorsing the truck over Tesla's Cybertruck. Options markets are decidedly constructive: call-to-put ratio stands at 4.88, with heavy buying concentrated in $16–$18 calls expiring July 2026. However, lingering headwinds—a NHTSA safety probe into 100,000+ vehicles for suspension defects and elevated near-term costs from R2 retooling—keep the stock under 52-week highs of $22.69.

Rocket Lab surged past $84 today after securing three dedicated Electron launches for NASA's PolSIR and TSIS-2 science missions starting 2027, marking a rare bright spot after the stock plummeted 44% from its $151 high. The aerospace firm's 10th consecutive successful mission and growing government contract wins contrast sharply with week-long selloff driven by rising component costs and capex concerns. Options traders are aggressively long, with call volume overwhelming puts at a 1.50 ratio; traders are building positions at $90 and $100 strikes expiring mid-2026, signaling conviction above current levels. Watch $90 as near-term resistance.